Delivery Order SPE2DR25D2105-SPE2DR26F5VCT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,119.24 to AmerisourceBergen Drug Corp for Belsomra 15 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,295.84 to AmerisourceBergen Drug Corp for Belsomra 20 mg tablets (30-count) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,069.68 to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 10 mg on July 30, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Belsomra 20 mg tablets (30-count) at a ceiling value of $1,088.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is classified as a child contract, meaning it derives from a larger indefinite delivery vehicle. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Belsomra 5 mg tablets (30-count) valued at $1,079.02. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the contractor's demonstrated capability to compete...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Belsomra 20 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,181.89 and an ultimate completion date of July 23, 2025. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Belsomra 10mg tablets (30-count) under a firm fixed-price contract valued at $1,072.12. This competitively awarded, non-set-aside delivery order is set to complete by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,185.57 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 20 mg, a pharmaceutical product for treating insomnia. This competitively awarded, firm fixed-price contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Belsomra 10 mg tablets. The firm-fixed-price contract has a ceiling value of $1,179.37 and a completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support federal healthcare programs and services. The contract is not set-aside and is part of a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, valued at $1,587.58, for the supply of Belsomra 20mg (30-count supply). Awarded on October 20, 2025, with an ultimate completion date of October 21, 2025, this firm fixed-price delivery order represents a non-set-aside competitive award. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- SPE2DR25D2105Indefinite Delivery Contract
- SPE2DR25D2105-SPE2DR26F5VCTDelivery Order
The Defense Logistics Agency awarded a $1,421.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Belsomra 15 mg tablets (30-count) on December 17, 2025, with completion targeted for December 18, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with the DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order derives from AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling supply of a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent competitive awards across multiple therapeutic domains, positioning the company as a critical vendor for federal medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/16/25 |